Search

Author/Creator Garg, M.

34. Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative). (19th July 2016)

Authors:
Chalmers, J.R.; Simpson, E.; Apfelbacher, C.J.; Thomas, K.S.; von Kobyletzki, L.; Schmitt, J.; Singh, J.A.; Svensson, Å.; Williams, H.C.; Abuabara, K.; Aoki, V.; Ardeleanu, M.; Awici‐Rasmussen, M.; Barbarot, S.; Berents, T.L.; Block, J.; Bragg, A.; Burton, T.; Bjerring Clemmensen, K.K.; Creswell‐...
Journal:
British journal of dermatology
Issue:
Volume 175:Number 1(2016)
Page Start:
69
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

35. Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative). (1st July 2016)

Authors:
Chalmers, J.R.; Simpson, E.; Apfelbacher, C.J.; Thomas, K.S.; von Kobyletzki, L.; Schmitt, J.; Singh, J.A.; Svensson, Å.; Williams, H.C.; Abuabara, K.; Aoki, V.; Ardeleanu, M.; Awici‐Rasmussen, M.; Barbarot, S.; Berents, T.L.; Block, J.; Bragg, A.; Burton, T.; Bjerring Clemmensen, K.K.; Creswell‐...
Journal:
British journal of dermatology
Issue:
Volume 175:Number 1(2016)
Page Start:
69
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

37. S291: PHASE I/II STUDY OF RILZABRUTINIB, AN ORAL BRUTON TYROSINE KINASE INHIBITOR, IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: LONG-TERM FOLLOW-UP. (23rd June 2022)

Authors:
Kuter, D. J.; Efraim, M.; Kaplan, Z.; Mayer, J.; Choi, P.; Jansen, A. G.; McDonald, V.; Baker, R.; Bird, R.; Garg, M.; Gumulec, J.; Kostal, M.; Gernsheimer, T.; Ghanima, W.; Yao, M.; Daak, A.; Cooper, N.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
192
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗